ArticleScientific reports2025
Intratracheal instillation of RSV is superior to intranasal inoculation as a model method inducing critical immune cell infiltration.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Respiratory syncytial virus (RSV) causes a substantial global disease burden, particularly in children and older adults. Despite the availability of three vaccines and two prophylactic monoclonal antibodies, there remains an urgent unmet need for effective RSV treatments. Appropriate experimental animal models and modeling methods are essential for studying RSV pathogenesis and developing therapeutic and preventive agents. In this study, we introduced intratracheal instillation (ITS) method into mouse model of RSV infection and compared it with the conventional intranasal inoculation (INO) method; data showed that ITS method resulted in more efficient viral replication and more severe pathological changes than INO method. Then RNA-seq technology was used to sequence the lung tissues of RSV infected mice with ITS method, and further immunoinfiltration analysis based on transcriptomic profile demonstrated that the ITS approach can lead to the infiltration of multiple innate and adaptive immune cells. It is concluded that ITS of RSV is superior to INO as a model method in mice and can induce infiltration of key immune cells. Collectively, our study offers novel insights into the rational design of future in vivo infection methods with RSV, as well as providing a foundation for the investigation of the immune pathogenesis of RSV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.